8 | AndrogensIBA
01/2022
-
07/2002 |
6 | Androgen Receptors (Androgen Receptor)IBA
06/2021
-
07/2002 |
4 | Proteins (Proteins, Gene)FDA Link
04/2019
-
12/2004 |
4 | OxalatesIBA
03/2012
-
11/2004 |
4 | 1,25-dihydroxyvitamin DIBA
11/2010
-
10/2002 |
4 | Prostate-Specific Antigen (Semenogelase)IBA
03/2009
-
07/2002 |
3 | Messenger RNA (mRNA)IBA
01/2022
-
10/2005 |
3 | InterferonsIBA
06/2020
-
12/2004 |
3 | Antiviral Agents (Antivirals)IBA
06/2020
-
12/2004 |
3 | DNA (Deoxyribonucleic Acid)IBA
10/2015
-
05/2009 |
3 | Cholecalciferol (Vitamin D3)FDA Link
01/2013
-
10/2002 |
2 | Biomarkers (Surrogate Marker)IBA
01/2021
-
09/2015 |
2 | Vitamin DFDA LinkGeneric
11/2015
-
06/2004 |
2 | hydroxide ionIBA
11/2015
-
06/2004 |
2 | ElementsIBA
09/2015
-
07/2002 |
2 | LipidsIBA
08/2015
-
10/2014 |
2 | glyoxylate reductaseIBA
03/2012
-
08/2006 |
2 | EnzymesIBA
05/2009
-
09/2004 |
2 | Calcifediol (Calcidiol)FDA Link
06/2004
-
11/2002 |
2 | Calcitriol (Calcijex)FDA LinkGeneric
06/2004
-
03/2004 |
2 | GenisteinIBA
03/2004
-
10/2002 |
1 | Histocompatibility Antigens Class IIBA
01/2024 |
1 | NF-kappa B (NF-kB)IBA
01/2024 |
1 | pembrolizumabIBA
04/2023 |
1 | AntigensIBA
04/2023 |
1 | Immune Checkpoint InhibitorsIBA
04/2023 |
1 | rho GTP-Binding Proteins (rho GTP-Binding Protein)IBA
01/2022 |
1 | enzalutamideIBA
01/2021 |
1 | Matrix-MIBA
06/2020 |
1 | NAD (NADH)IBA
11/2018 |
1 | Cyclic ADP-Ribose (cADPR)IBA
11/2018 |
1 | EndotoxinsIBA
11/2015 |
1 | Silybin (Lagosa)IBA
09/2015 |
1 | Glucose (Dextrose)FDA LinkGeneric
08/2015 |
1 | STAT1 Transcription FactorIBA
05/2015 |
1 | Orlistat (Xenical)FDA Link
10/2014 |
1 | etomoxirIBA
10/2014 |
1 | Genetic Markers (Genetic Marker)IBA
07/2013 |
1 | Hydroxyproline (4 Hydroxyproline)IBA
03/2012 |
1 | glyoxylic acid (glyoxylate)IBA
03/2012 |
1 | Alanine-glyoxylate transaminase (alanine-glyoxylate aminotransferase)IBA
03/2012 |
1 | Hydroxypyruvate ReductaseIBA
03/2012 |
1 | Calcium OxalateIBA
03/2012 |
1 | Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA
02/2012 |
1 | omega-3 fatty acid desaturaseIBA
02/2012 |
1 | Proteasome Endopeptidase Complex (Proteasome)IBA
02/2012 |
1 | 4- cyclohexyl- 1- (1,2- diphenylethyl)piperazine (cdep)IBA
01/2012 |
1 | triciribineIBA
11/2010 |
1 | GSK690693IBA
11/2010 |
1 | API 2IBA
11/2010 |
1 | MicroRNAs (MicroRNA)IBA
05/2010 |
1 | Peptide Hydrolases (Proteases)FDA Link
09/2008 |
1 | 5-oxo-eicosatetraenoic acidIBA
10/2005 |
1 | Pertussis ToxinIBA
10/2005 |
1 | 5-oxo-6,8,11,14-eicosatetraenoic acidIBA
10/2005 |
1 | GTP-Binding Proteins (G-Protein)IBA
10/2005 |
1 | 5-hydroxy-6,8,11,14-eicosatetraenoic acidIBA
10/2005 |
1 | Complement System Proteins (Complement)IBA
05/2005 |
1 | cyclopropapyrroloindoleIBA
04/2005 |
1 | Mutant Proteins (Protein, Mutant)IBA
12/2004 |
1 | TransferasesIBA
09/2004 |
1 | ADP Ribose Transferases (ADP Ribosyltransferase)IBA
09/2004 |
1 | Adenosine Diphosphate (ADP)IBA
09/2004 |
1 | Mixed Function Oxygenases (Monooxygenases)IBA
06/2004 |
1 | SteroidsIBA
06/2004 |
1 | Hormones (Hormone)IBA
06/2004 |
1 | Calcitriol Receptors (Calcitriol Receptor)IBA
03/2004 |
1 | NucleotidesIBA
07/2003 |
1 | LuciferasesIBA
07/2003 |
1 | Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA
12/2002 |
1 | 25-Hydroxyvitamin D3 1-alpha-Hydroxylase (25 Hydroxyvitamin D3 1 alpha Hydroxylase)IBA
11/2002 |